These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24556396)

  • 1. MAITs, MR1 and vitamin B metabolites.
    Birkinshaw RW; Kjer-Nielsen L; Eckle SB; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2014 Feb; 26():7-13. PubMed ID: 24556396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAIT cells and MR1-antigen recognition.
    Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR1 presentation of vitamin B-based metabolite ligands.
    McWilliam HE; Birkinshaw RW; Villadangos JA; McCluskey J; Rossjohn J
    Curr Opin Immunol; 2015 Jun; 34():28-34. PubMed ID: 25603223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
    Mondot S; Boudinot P; Lantz O
    Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
    Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell activation by transitory neo-antigens derived from distinct microbial pathways.
    Corbett AJ; Eckle SB; Birkinshaw RW; Liu L; Patel O; Mahony J; Chen Z; Reantragoon R; Meehan B; Cao H; Williamson NA; Strugnell RA; Van Sinderen D; Mak JY; Fairlie DP; Kjer-Nielsen L; Rossjohn J; McCluskey J
    Nature; 2014 May; 509(7500):361-5. PubMed ID: 24695216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
    Corbett AJ; Awad W; Wang H; Chen Z
    Front Immunol; 2020; 11():1961. PubMed ID: 32973800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
    Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
    J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of vitamin B metabolites by mucosal-associated invariant T cells.
    Patel O; Kjer-Nielsen L; Le Nours J; Eckle SB; Birkinshaw R; Beddoe T; Corbett AJ; Liu L; Miles JJ; Meehan B; Reantragoon R; Sandoval-Romero ML; Sullivan LC; Brooks AG; Chen Z; Fairlie DP; McCluskey J; Rossjohn J
    Nat Commun; 2013; 4():2142. PubMed ID: 23846752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.
    López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ
    Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
    Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
    Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of T Cells Restricted by the MHC Class I-Related Molecule MR1 Facilitates Differential Antigen Recognition.
    Gherardin NA; Keller AN; Woolley RE; Le Nours J; Ritchie DS; Neeson PJ; Birkinshaw RW; Eckle SBG; Waddington JN; Liu L; Fairlie DP; Uldrich AP; Pellicci DG; McCluskey J; Godfrey DI; Rossjohn J
    Immunity; 2016 Jan; 44(1):32-45. PubMed ID: 26795251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR1 presents microbial vitamin B metabolites to MAIT cells.
    Kjer-Nielsen L; Patel O; Corbett AJ; Le Nours J; Meehan B; Liu L; Bhati M; Chen Z; Kostenko L; Reantragoon R; Williamson NA; Purcell AW; Dudek NL; McConville MJ; O'Hair RA; Khairallah GN; Godfrey DI; Fairlie DP; Rossjohn J; McCluskey J
    Nature; 2012 Nov; 491(7426):717-23. PubMed ID: 23051753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAIT recognition of a stimulatory bacterial antigen bound to MR1.
    López-Sagaseta J; Dulberger CL; McFedries A; Cushman M; Saghatelian A; Adams EJ
    J Immunol; 2013 Nov; 191(10):5268-77. PubMed ID: 24108697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Makes MAITs Wait?
    Exley MA
    Immunity; 2016 Jan; 44(1):7-9. PubMed ID: 26789915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR1-restricted V alpha 19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response.
    Kawachi I; Maldonado J; Strader C; Gilfillan S
    J Immunol; 2006 Feb; 176(3):1618-27. PubMed ID: 16424191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
    Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
    J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage.
    Gold MC; McLaren JE; Reistetter JA; Smyk-Pearson S; Ladell K; Swarbrick GM; Yu YY; Hansen TH; Lund O; Nielsen M; Gerritsen B; Kesmir C; Miles JJ; Lewinsohn DA; Price DA; Lewinsohn DM
    J Exp Med; 2014 Jul; 211(8):1601-10. PubMed ID: 25049333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells.
    Laugel B; Lloyd A; Meermeier EW; Crowther MD; Connor TR; Dolton G; Miles JJ; Burrows SR; Gold MC; Lewinsohn DM; Sewell AK
    J Immunol; 2016 Aug; 197(3):971-82. PubMed ID: 27307560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.